Structure of Human Eg5 in Complex with a New Monastrol-based Inhibitor Bound in the R Configuration*
暂无分享,去创建一个
Pierre Thuéry | Bernard Rousseau | Roman Lopez | P. Thuéry | F. Kozielski | Frank Kozielski | I. Garcia-Saez | S. Debonis | Isabel Garcia-Saez | Salvatore DeBonis | Fernando Trucco | B. Rousseau | R. Lopez | Fernando Trucco
[1] H. Flack,et al. On enantiomorph‐polarity estimation , 1983 .
[2] Stephen S. Taylor,et al. Aurora-kinase inhibitors as anticancer agents , 2004, Nature Reviews Cancer.
[3] J Guo,et al. Crystal Structure of the Mitotic Spindle Kinesin Eg5 Reveals a Novel Conformation of the Neck-linker* , 2001, The Journal of Biological Chemistry.
[4] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[5] G Vriend,et al. WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.
[6] J M Thornton,et al. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.
[7] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[8] David S. Wishart,et al. SuperPose: a simple server for sophisticated structural superposition , 2004, Nucleic Acids Res..
[9] Yijun Huang,et al. Highly enantioselective Biginelli reaction using a new chiral ytterbium catalyst: asymmetric synthesis of dihydropyrimidines. , 2006, Journal of the American Chemical Society.
[10] C. Kappe. Biologically active dihydropyrimidones of the Biginelli-type--a literature survey. , 2000, European journal of medicinal chemistry.
[11] Timothy J. Mitchison,et al. Determining the position of the cell division plane , 2003, Nature.
[12] Weikang Tao,et al. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. , 2005, Cancer cell.
[13] P. Gans,et al. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5. , 2003, Biochemistry.
[14] L. Mueller,et al. Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[15] Wayne Vaccaro,et al. Inhibitors of human mitotic kinesin Eg5: characterization of the 4-phenyl-tetrahydroisoquinoline lead series. , 2006, Bioorganic & medicinal chemistry letters.
[16] K. Brejc,et al. Mitotic kinesins: prospects for antimitotic drug discovery. , 2005, Current topics in medicinal chemistry.
[17] R. Copeland,et al. Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition. , 2004, Biochemistry.
[18] H. Lane,et al. Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo , 1995, Cell.
[19] Wolfgang Kabsch,et al. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .
[20] Ryo Nitta,et al. KIF1A Alternately Uses Two Loops to Bind Microtubules , 2004, Science.
[21] Youwei Yan,et al. Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP. , 2006, Bioorganic & medicinal chemistry letters.
[22] M. Elkabets,et al. Differential effects of monastrol in two human cell lines , 2004, Cellular and Molecular Life Sciences CMLS.
[23] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[24] S. Sabbatini,et al. Improved synthesis and preparative scale resolution of racemic monastrol , 2002 .
[25] Paul J Coleman,et al. Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP. , 2005, Bioorganic & medicinal chemistry letters.
[26] R. Cross,et al. Monastrol stabilises an attached low-friction mode of Eg5 , 2004, Current Biology.
[27] Lawrence C Kuo,et al. Inhibition of a mitotic motor protein: where, how, and conformational consequences. , 2004, Journal of molecular biology.
[28] S. Rosenfeld,et al. Docking and Rolling, a Model of How the Mitotic Motor Eg5 Works* , 2005, Journal of Biological Chemistry.
[29] Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP. , 2006, Bioorganic & medicinal chemistry letters.
[30] Paraskevi Giannakakou,et al. Mitotic Kinesin Inhibitors Induce Mitotic Arrest and Cell Death in Taxol-resistant and -sensitive Cancer Cells* , 2005, Journal of Biological Chemistry.
[31] Timothy J Mitchison,et al. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5. , 2002, Chemistry & biology.
[32] S. Trehan,et al. Asymmetric reduction of aromatic ketones: importance of the conformation of the aromatic group , 1998 .
[33] T. Kapoor,et al. Monastrol Inhibition of the Mitotic Kinesin Eg5* , 2005, Journal of Biological Chemistry.
[34] S. Haggarty,et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. , 1999, Science.
[35] Jorge Navaza,et al. [33] AMoRe: An automated molecular replacement program package. , 1997, Methods in enzymology.
[36] S. Rosenfeld,et al. A Pathway of Structural Changes Produced by Monastrol Binding to Eg5* , 2006, Journal of Biological Chemistry.
[37] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[38] A. Ullrich,et al. Targeting polo-like kinase 1 for cancer therapy , 2006, Nature Reviews Cancer.
[39] Jared C Cochran,et al. ATPase mechanism of Eg5 in the absence of microtubules: insight into microtubule activation and allosteric inhibition by monastrol. , 2005, Biochemistry.